Calidi Biotherapeutics’ $6.1 Million Common Stock Public Offering

Lewis Brisbois Bisgaard & Smith represented Calidi, while Sheppard, Mullin, Richter & Hampton represented the placement agent in the transaction.Calidi Biotherapeutics, Inc. announced its $6.1 million…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here